Net Cash Provided by (Used in) Financing Activities of NexImmune, Inc. from 31 Mar 2020 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
NexImmune, Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Mar 2020 to 31 Mar 2024.
  • NexImmune, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2024 was $3,143,949.
  • NexImmune, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $0, a 100% decline from 2022.
  • NexImmune, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $5,178,664, a 96% decline from 2021.
  • NexImmune, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $124,887,625, a 465% increase from 2020.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

NexImmune, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $3,143,949 +$3,143,949 01 Jan 2024 31 Mar 2024 10-Q 20 May 2024 2024 Q1
Q1 2023 $0 -$33,255 -100% 01 Jan 2023 31 Mar 2023 10-Q 20 May 2024 2024 Q1
Q1 2022 $33,255 -$124,774,907 -100% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q1 2021 $124,808,162 +$124,812,994 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q1 2020 $4,832* 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1

NexImmune, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $0 -$5,178,664 -100% 01 Jan 2023 31 Dec 2023 10-K 16 Apr 2024 2023 FY
2022 $5,178,664 -$119,708,961 -96% 01 Jan 2022 31 Dec 2022 10-K 16 Apr 2024 2023 FY
2021 $124,887,625 +$102,802,768 +465% 01 Jan 2021 31 Dec 2021 10-K 28 Mar 2023 2022 FY
2020 $22,084,857 01 Jan 2020 31 Dec 2020 10-K 09 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.